Drugs / ST316
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05848739 | Jun 2023 → May 2026 overdue | colorectal cancer | Sapience Therapeutics | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ST316 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05848739 ↗ |
| Route | Intravenous | “ST316 administered IV” NCT05848739 ↗ |